Can’t find what you’re looking for? Contact us.

Or, need help ordering? 805.528.4341

Filter Samples By:

Get Weekly Research Sample Updates in your Inbox:

Longitudinal Hepatitis C (HCV) Drug Treatment Sample Set Clinical Research Samples

Discovery Life Sciences provides the highest quality Longitudinal Hepatitis C (HCV) Drug Treatment Sample Set Clinical Research Samples and Residual Diagnostic Specimens from the Life Science Industry’s only convenient online, open access Biobank. 

  • All Longitudinal Hepatitis C (HCV) Drug Treatment Sample Set Sample Orders are Packaged for Delivery within 24 Hours. 
  • All Specimens Ethically Obtained, De-Identified and provided with Highly Annotated Demographic and Clinical Data.
  • Select from an HHS/OHRP Compliant Biorepository following ISBER/BBRB Guidelines.
  • Packaged in Compliance with all UN Regulations (6.2) and U.S. DOT Hazmat regulations. 
Showing 28 of 28 total samples
 (0)
Checkout
Advanced Data View:
Showing 28 of 28 total samples
Buy
Product IDSampleOriginMatrixVial (ml)QuantityPriceAgeGenderEthnicityStorage TempSample DateTest 1Test Data 1Sample Detail 1Test 2Test Data 2Product
Details
Price
Buy
Additional Information 1Additional Data 1Additional Information 2Additional Data 2Additional Information 3Additional Data 3Additional Information 4Additional Data 4Additional Information 5Additional Data 5Additional Information 6Additional Data 6Additional Detail 6Additional Information 7Additional Data 7
DLS14-13769-02Longitudinal Hepatitis C (HCV) Drug Treatment Sample SetUSASerum1.004.00$200.0059 YFWhite<-70C09-Apr-15Genotype4$200.00
DLS14-13733-01Longitudinal Hepatitis C (HCV) Drug Treatment Sample SetUSASerum1.005.00$200.0065 YMBlack<-70C13-Feb-15Genotype4$200.00
DLS14-13733-02Longitudinal Hepatitis C (HCV) Drug Treatment Sample SetUSASerum1.008.00$200.0065 YMBlack<-70C13-Mar-15Genotype4$200.00
DLS14-13763-01Longitudinal Hepatitis C (HCV) Drug Treatment Sample SetUSASerum1.007.00$200.0063 YMU/A<-70C29-Oct-14Genotype4$200.00
DLS14-13763-02Longitudinal Hepatitis C (HCV) Drug Treatment Sample SetUSASerum1.0011.00$200.0063 YMU/A<-70C30-Jan-15Genotype4$200.00
DLS14-13763-03Longitudinal Hepatitis C (HCV) Drug Treatment Sample SetUSASerum1.008.00$200.0064 YMU/A<-70C22-Jun-15Genotype4$200.00
DLS14-13769-03Longitudinal Hepatitis C (HCV) Drug Treatment Sample SetUSASerum1.007.00$200.0060 YFWhite<-70C05-Jun-15Genotype4$200.00
DLS14-13733-03Longitudinal Hepatitis C (HCV) Drug Treatment Sample SetUSASerum1.0012.00$200.0065 YMBlack<-70C31-Jul-15Genotype4$200.00
DLS14-13733-04Longitudinal Hepatitis C (HCV) Drug Treatment Sample SetUSASerum1.009.00$200.0066 YMBlack<-70C23-Oct-15Genotype4$200.00
DLS14-13763-04Longitudinal Hepatitis C (HCV) Drug Treatment Sample SetUSASerum1.0011.00$200.0064 YMU/A<-70C28-Sep-15Genotype4$200.00
DLS14-24761-01Longitudinal Hepatitis C (HCV) Drug Treatment Sample SetSouth AfricaSerum1.006.00$200.0066 YFWhite<-70C20-Jul-15Genotype4b$200.00
DLS14-24761-02Longitudinal Hepatitis C (HCV) Drug Treatment Sample SetSouth AfricaSerum1.0014.00$200.0066 YFWhite<-70C24-Aug-15Genotype4b$200.00
DLS14-24761-03Longitudinal Hepatitis C (HCV) Drug Treatment Sample SetSouth AfricaSerum1.009.00$200.0067 YFWhite<-70C08-Mar-16Genotype4b$200.00
DLS14-24763-02Longitudinal Hepatitis C (HCV) Drug Treatment Sample SetSouth AfricaSerum1.004.00$200.0075 YFWhite<-70C21-Dec-16Genotype5a$200.00
DLS14-24764-01Longitudinal Hepatitis C (HCV) Drug Treatment Sample SetSouth AfricaSerum1.008.00$200.00 MAsian<-70CGenotype5a$200.00
DLS14-24764-02Longitudinal Hepatitis C (HCV) Drug Treatment Sample SetSouth AfricaSerum1.0014.00$200.00 MAsian<-70CGenotype5a$200.00
DLS14-24765-01Longitudinal Hepatitis C (HCV) Drug Treatment Sample SetSouth AfricaSerum1.006.00$200.0062 YMWhite<-70C02-Mar-17Genotype5a$200.00
DLS14-24771-01Longitudinal Hepatitis C (HCV) Drug Treatment Sample SetSouth AfricaSerum1.007.00$200.0071 YMWhite<-70C09-Nov-16Genotype5a$200.00
DLS14-24771-02Longitudinal Hepatitis C (HCV) Drug Treatment Sample SetSouth AfricaSerum1.004.00$200.0071 YMWhite<-70C07-Dec-16Genotype5a$200.00
DLS14-24763-04Longitudinal Hepatitis C (HCV) Drug Treatment Sample SetSouth AfricaSerum1.006.00$200.00 FWhite<-70C14-Aug-17Genotype5a$200.00
DLS14-24764-03Longitudinal Hepatitis C (HCV) Drug Treatment Sample SetSouth AfricaSerum1.009.00$200.00 MAsian<-70C30-May-17Genotype5a$200.00
DLS14-24764-04Longitudinal Hepatitis C (HCV) Drug Treatment Sample SetSouth AfricaSerum1.006.00$200.00 MAsian<-70C08-Aug-17Genotype5a$200.00
DLS14-24765-02Longitudinal Hepatitis C (HCV) Drug Treatment Sample SetSouth AfricaSerum1.0010.00$200.00 MWhite<-70C03-Apr-17Genotype5a$200.00
DLS14-24765-03Longitudinal Hepatitis C (HCV) Drug Treatment Sample SetSouth AfricaSerum1.006.00$200.00 MWhite<-70C28-Aug-17Genotype5a$200.00
DLS14-24765-04Longitudinal Hepatitis C (HCV) Drug Treatment Sample SetSouth AfricaSerum1.006.00$200.00 MWhite<-70C20-Nov-17Genotype5a$200.00
DLS14-24771-03Longitudinal Hepatitis C (HCV) Drug Treatment Sample SetSouth AfricaSerum1.004.00$200.00 MWhite<-70C10-May-17Genotype5a$200.00
DLS14-24771-04Longitudinal Hepatitis C (HCV) Drug Treatment Sample SetSouth AfricaSerum1.006.00$200.00 MWhite<-70C16-Aug-17Genotype5a$200.00
DLS0060738-01Longitudinal Hepatitis C (HCV) Drug Treatment Sample SetUSASerum1.0016.00$200.0064 YMBlack<-70C18-Jul-18Abbott RealTime PCR Assay272,816 IU/mL13-Jul-18GenotypeN/A$200.00Additional Testing NoneDate of HCV DiagnosisN/AHCV Risk GroupNoneHeight | WeightN/ALiver Biopsy?NoFibroscan?Yes | F4 Fibrosis S>1 Steatosis 13-Jun-18Medication NameEpclusa

Keep in mind that all the samples comprised in the Research Sample Biobank represent only a small number of the clinical research specimens available through our Discovery Partners™ clinical research programs. If you can’t find the specific sample type, specimen or biofluids you are looking for please make sure to call our client services group at 805.528.4341 - and ask how we can help support your project from resources available at active clinical sites.

Please read carefully before purchasing:

Clinical specimens for research use only.

Transmissible Infectious Risk! May be HIV, HBV and HCV REACTIVE or of unknown infectious agent test status. Materials provided are derived from human blood, tissue and other bio-fluids. Handle all samples as if capable of transmitting infectious agents. Practice good laboratory technique and dispose of in properly marked medical waste.

If you need help searching for a LARGER SAMPLE SET with specific data elements, please contact our Client Services group who can format Excel spreadsheets for a comprehensive review of all available samples: USA (805) 528-4341

These products are supplied without warranty for suitability for specific applications or analytical determinations.

Specimens and data will be may be used for general biomarker research, assay and instrument validation purposes only. All Research products identified as “Diagnostic Remnant Samples” are human biological materials leftover from routine laboratory analysis and are de-identified (coded) to protect subject confidentiality. Under OHRP definition 45 CFR 46.102(f) these coded specimens are not considered subjects for Human research requiring informed consent. Specimens cannot be used for whole genomic sequencing of genetic material. Research products designated as “Clinical Research Samples” by “type” are obtained from IRB approved research study protocols with informed consent obtained from each subject enrolled. Specimens cannot be used for whole genomic sequencing of genetic material.